Pfizer will retain some of its "pharmaceutical sciences operations" at its R&D facility in Sandwich, UK, a move which will preserve about 350 jobs.
This is the most positive news to come out of the site in Kent since February, when the US giant announced that the major facility, which employed 2,400 people, would close. Pfizer now says the staff that are retained will support the development of products in the mid- and late- stage pipeline and will review this operation within a few years, as part of its normal business planning.
via pharmatimes.com
No comments:
Post a Comment